Back to search
FDAFDA · Food and drugs·Recall number D-1539-2014

Tolterodine Tartrate Tablets, 1 mg, 60 Tablet Bottles, Rx only. Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-5445-91.

Published August 27, 2014 · Recall initiated: June 20, 2014

Summary

FDA records drug Class III recall D-1539-2014, published August 27, 2014 and initiated June 20, 2014. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 9225 Bottles; Lot: Lot # 2004069, Expiry: 09/2014; Lot #: 2004070, Expiry: 09/2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
U.S. Nationwide
Lot
Lot # 2004069, Expiry: 09/2014; Lot #: 2004070, Expiry: 09/2014.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tolterodine Tartrate Tablets, 1 mg, 60 Tablet Bottles, Rx only. Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-5445-91. recalled?

Yes. FDA published recall D-1539-2014 on August 27, 2014. Reported hazard: Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail